Introduction

In the fast-evolving field of RNA therapeutics, the ability to efficiently deliver RNA molecules in vivo is critical for validating function, screening candidates, and accelerating preclinical development. Traditional RNA delivery solutions can be time-consuming, costly, and technically demanding—especially during early-stage research involving low-dose samples and multiple mRNA sequences.

LNP delivery has solved the "does it work" question for RNA therapeutics, it hasn't solved the "does it work everywhere, every time" question. Three problems keep surfacing across the field: organ targeting (most LNPs default to the liver, and steering payload to lung, spleen, or immune cells still requires extensive formulation tuning), encapsulation efficiency (a small shift in lipid ratios can swing efficiency from over 90% to under 65%, as we saw in the Ab-LNP structures behind in vivo CAR-T), and batch-to-batch stability (a formulation that holds together in a bench-top prep doesn't always survive scale-up or freeze-thaw cycles).

That's the gap a ready-to-use kit is actually closing not "encapsulation is hard, so here's a shortcut," but "these three variables are where most labs lose time, so we've pre-solved them."

To address this challenge, Hzymes Biotech has launched the Fast LNP (in vivo - systemic delivery) Ready-to-Use Kit, a cutting-edge solution designed for rapid, efficient, and scalable RNA delivery in animal models.

Advantage

Application Scenario

Applications

LNP delivery is the mechanism behind one of the fastest-moving fields in cell therapy right now: in vivo CAR-T. Every antibody-conjugated LNP platform in that space, the ones behind AbbVie, BMS, Gilead, AstraZeneca, and Lilly's recent bets, depends on exactly the same formulation variables this kit is built to standardize: ionizable lipid ratio, encapsulation efficiency, and targeting specificity. (For a deeper look at how those platforms work, see our breakdown of the in vivo CAR-T landscape.)

This product can transcend the cellular level validation and directly carry out ultra-fast and low-cost in vivo validation, especially for the early stage of research with many mRNA sequences but the dosage of experimental samples is low, lt can accurately and rapidly complete the validation and screening of the translational level and function of mRNAs in vivo, Hzymes can provide in vivo validation service based on this product, directly provide in vivo expression efficiency results, with professional customized solutions to launch quality services.

Highly efficient 1-min-encapsulation of mRNA

Product Information

Compatible with multiple modes of administration

Conclusion

The Fast LNP (in vivo) Ready-to-Use Kit is a powerful tool for any lab working on RNA delivery, gene therapy, or mRNA vaccine development. With its rapid encapsulation, broad compatibility, and in vivo focus, it enables faster, more confident decision-making in the preclinical research pipeline.

Don’t let delivery bottlenecks slow you down. Accelerate your RNA validation projects today with Hzymes' Fast LNP Kit.